https://www.europesays.com/1672520/ SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate’s Dual Mechanism of Action #america #AmericanEpilepsySociety #Biopharmaceuticals #cenobamate #HealthcareProvider #LifeScience #patients #science #technology #UnitedStates #UnitedStatesOfAmerica #US #USA #XCOPRI